General information
Sanofi-Aventis Deutschland GmbH
Industriepark Höchst
K703
65926 Frankfurt, Hessen
Germany
Contact person: Anne Reuschenbach, General Manager
Company main phone: +49 (69) 30580710
Company main fax: +49 (69) 30516883
Website: https://www.sanofi.de
Source of foundation: | Subsidiary |
Name of foundation source: | Sanofi Group, France |
No. of employees: |
Worldwide: 100000 |
Corporate description / mission:
Sanofi-Aventis Deutschland GmbH manufactures and markets medicines, serums, and vaccines. The company's products are used to treat diabetes, cancer, heart failures, strokes, allergies, asthma, skin diseases, multiple sclerosis, osteoporosis, and tinnitus.
Frankfurt location covers the entire value chain from research and development as well as production and manufacturing for modern biologicals, the importance of which for medical care is constantly increasing.
State of ownership: Subsidiary
Headquarters: No
Categorization
Sector: |
- Pharma (fully integrated)
|
Subsector: |
- Antibodies
- Proteins
- Small molecule therapeutics
- Vaccines
|
Primary therapeutic areas: |
- Cardiovascular / cardiology
- Diseases of the nervous system / neurology
- Endocrine, nutritional and metabolic diseases / endocrinology
- Infectious and parasitic diseases / infectiology / parasitology
- Musculoskeletal system and connective tissue / Orthopedics
- Neoplasms / cancer / oncology
- Respiratory / pulmonology
- Skin and subcutaneous tissue / dermatology
|
Business model: |
- Manufacturer
- R&D
- Subsidiary
- Supplier / Distributor
|
Customer segments: |
- Hospitals
- Large biotech & big pharma
- Physicians / doctors
- Small biotech
|
Summary Products / Services / Technologies
Description of products:
Ergenyl ®
Caprelsa ®
Aubagio ®
Lemtrada ®, etc.